Sinotau

先通医药 – 先通医药

Guangdong, China · Founded 2014 · $252.0M raised

Headquarters
Guangdong
Employees
201–500
Founded
2014
Business Model
B2B
Total Funding
$252.0M
Last Round
$152.0M Venture RoundJul 2023
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sinotau is a Chinese radiopharmaceutical company focused on researching, developing, manufacturing, clinically applying, and academically promoting innovative radiopharmaceuticals. It has pursued next-generation products since 2014 across oncology, neurology, and cardiology. The company develops diagnostic and therapeutic solutions designed to improve treatment outcomes and patients' quality of life.

Summary

Sinotau is a Biotech company based in Guangdong, China, founded in 2014. It has raised $252.0M in total across 3 rounds, most recently a $152.0M Venture Round in Jul 2023. Investors include China Life Private Equity, CICC and Centurium Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJul 2023
$152.0M

Sign up to see all 3 events

Funding: Series D through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sinotau on Indexed.vc
<a href="https://indexed.vc/companies/sinotau"><img src="https://indexed.vc/api/badge/company/sinotau" alt="Sinotau on Indexed.vc" width="260" height="76" /></a>